APO Research
Talk to an analyst

APO RESEARCH · REPORT

Arbidol Hydrochloride (COVID-19)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Arbidol Hydrochloride (COVID-19) Industry Growth and Trends Forecast to 2032

2 January 202691 pages

Choose your research edition.

Industry ResearchArbidol Hydrochloride (COVID-19) Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Arbidol Hydrochloride (COVID-19) Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Arbidol Hydrochloride (COVID-19) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Arbidol Hydrochloride (COVID-19) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Arbidol Hydrochloride (COVID-19) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Arbidol Hydrochloride (COVID-19) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Arbidol Hydrochloride (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Arbidol Hydrochloride (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Arbidol Hydrochloride (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Arbidol Hydrochloride (COVID-19) include Simcere Pharmaceutical, CSPC Ouyi Pharmaceutical, Jiangsu Wuzhong Pharmaceutical, Jiangsu Lianshui Pharmaceutical and JSC Pharmstandard, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Arbidol Hydrochloride (COVID-19) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Arbidol Hydrochloride (COVID-19) market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Arbidol Hydrochloride (COVID-19) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Arbidol Hydrochloride (COVID-19).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Arbidol Hydrochloride (COVID-19) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Arbidol Hydrochloride (COVID-19) Market by Company

Simcere Pharmaceutical

CSPC Ouyi Pharmaceutical

Jiangsu Wuzhong Pharmaceutical

Jiangsu Lianshui Pharmaceutical

JSC Pharmstandard

Arbidol Hydrochloride (COVID-19) Segment by Type

Arbidol Hydrochloride Capsules

Arbidol Hydrochloride Granules

Arbidol Hydrochloride Tablets

Arbidol Hydrochloride (COVID-19) Segment by Application

Anti Influenza Virus

COVID-19

Arbidol Hydrochloride (COVID-19) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arbidol Hydrochloride (COVID-19) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Arbidol Hydrochloride (COVID-19) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arbidol Hydrochloride (COVID-19).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Arbidol Hydrochloride (COVID-19) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Arbidol Hydrochloride (COVID-19) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Arbidol Hydrochloride Capsules Table 2. Major Company of Arbidol Hydrochloride Granules Table 3. Major Company of Arbidol Hydrochloride Tablets Table 4. Global Arbidol Hydrochloride (COVID-19) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Arbidol Hydrochloride (COVID-19) Sales by Type (2021-2026) & (K Units) Table 6. Global Arbidol Hydrochloride (COVID-19) Sales Market Share in Volume by Type (2021-2026) Table 7. Global Arbidol Hydrochloride (COVID-19) Sales by Type (2021-2026) & (US$ Million) Table 8. Global Arbidol Hydrochloride (COVID-19) Sales Market Share in Value by Type (2021-2026) Table 9. Global Arbidol Hydrochloride (COVID-19) Price by Type (2021-2026) & (US$/Unit) Table 10. Global Arbidol Hydrochloride (COVID-19) Sales by Type (2027-2032) & (K Units) Table 11. Global Arbidol Hydrochloride (COVID-19) Sales Market Share in Volume by Type (2027-2032) Table 12. Global Arbidol Hydrochloride (COVID-19) Sales by Type (2027-2032) & (US$ Million) Table 13. Global Arbidol Hydrochloride (COVID-19) Sales Market Share in Value by Type (2027-2032) Table 14. Global Arbidol Hydrochloride (COVID-19) Price by Type (2027-2032) & (US$/Unit) Table 15. North America Arbidol Hydrochloride (COVID-19) Sales by Type (2021-2026) & (K Units) Table 16. North America Arbidol Hydrochloride (COVID-19) Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Arbidol Hydrochloride (COVID-19) Sales by Type (2021-2026) & (K Units) Table 18. Europe Arbidol Hydrochloride (COVID-19) Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Arbidol Hydrochloride (COVID-19) Sales by Type (2021-2026) & (K Units) Table 22. Latin America Arbidol Hydrochloride (COVID-19) Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales by Type (2021-2026) & (US$ Million) Table 25. Arbidol Hydrochloride (COVID-19) Industry Trends Table 26. Arbidol Hydrochloride (COVID-19) Industry Drivers Table 27. Arbidol Hydrochloride (COVID-19) Industry Opportunities and Challenges Table 28. Arbidol Hydrochloride (COVID-19) Industry Restraints Table 29. Global Arbidol Hydrochloride (COVID-19) Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Company (2021-2026) Table 31. Global Arbidol Hydrochloride (COVID-19) Sales by Company (2021-2026) & (K Units) Table 32. Global Arbidol Hydrochloride (COVID-19) Sales Share by Company (2021-2026) Table 33. Global Arbidol Hydrochloride (COVID-19) Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Arbidol Hydrochloride (COVID-19) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Arbidol Hydrochloride (COVID-19) Major Company Production Sites and Headquarters Table 36. Global Arbidol Hydrochloride (COVID-19) Company, Product Type & Application Table 37. Global Arbidol Hydrochloride (COVID-19) Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Arbidol Hydrochloride (COVID-19) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Arbidol Hydrochloride (COVID-19) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Arbidol Hydrochloride (COVID-19) Sales by Region (2021-2026) & (K Units) Table 42. Global Arbidol Hydrochloride (COVID-19) Sales Market Share in Volume by Region (2021-2026) Table 43. Global Arbidol Hydrochloride (COVID-19) Sales by Region (2021-2026) & (US$ Million) Table 44. Global Arbidol Hydrochloride (COVID-19) Sales Market Share in Value by Region (2021-2026) Table 45. Global Arbidol Hydrochloride (COVID-19) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Arbidol Hydrochloride (COVID-19) Sales by Region (2027-2032) & (K Units) Table 47. Global Arbidol Hydrochloride (COVID-19) Sales Market Share in Volume by Region (2027-2032) Table 48. Global Arbidol Hydrochloride (COVID-19) Sales by Region (2027-2032) & (US$ Million) Table 49. Global Arbidol Hydrochloride (COVID-19) Sales Market Share in Value by Region (2027-2032) Table 50. Global Arbidol Hydrochloride (COVID-19) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Arbidol Hydrochloride (COVID-19) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Arbidol Hydrochloride (COVID-19) Sales by Application (2021-2026) & (K Units) Table 53. Global Arbidol Hydrochloride (COVID-19) Sales Market Share in Volume by Application (2021-2026) Table 54. Global Arbidol Hydrochloride (COVID-19) Sales by Application (2021-2026) & (US$ Million) Table 55. Global Arbidol Hydrochloride (COVID-19) Sales Market Share in Value by Application (2021-2026) Table 56. Global Arbidol Hydrochloride (COVID-19) Price by Application (2021-2026) & (US$/Unit) Table 57. Global Arbidol Hydrochloride (COVID-19) Sales by Application (2027-2032) & (K Units) Table 58. Global Arbidol Hydrochloride (COVID-19) Sales Market Share in Volume by Application (2027-2032) Table 59. Global Arbidol Hydrochloride (COVID-19) Sales by Application (2027-2032) & (US$ Million) Table 60. Global Arbidol Hydrochloride (COVID-19) Sales Market Share in Value by Application (2027-2032) Table 61. Global Arbidol Hydrochloride (COVID-19) Price by Application (2027-2032) & (US$/Unit) Table 62. North America Arbidol Hydrochloride (COVID-19) Sales by Application (2021-2026) & (K Units) Table 63. North America Arbidol Hydrochloride (COVID-19) Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Arbidol Hydrochloride (COVID-19) Sales by Application (2021-2026) & (K Units) Table 65. Europe Arbidol Hydrochloride (COVID-19) Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Arbidol Hydrochloride (COVID-19) Sales by Application (2021-2026) & (K Units) Table 69. Latin America Arbidol Hydrochloride (COVID-19) Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales by Application (2021-2026) & (US$ Million) Table 72. Simcere Pharmaceutical Company Information Table 73. Simcere Pharmaceutical Business Overview Table 74. Simcere Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Simcere Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio Table 76. Simcere Pharmaceutical Recent Development Table 77. CSPC Ouyi Pharmaceutical Company Information Table 78. CSPC Ouyi Pharmaceutical Business Overview Table 79. CSPC Ouyi Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. CSPC Ouyi Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio Table 81. CSPC Ouyi Pharmaceutical Recent Development Table 82. Jiangsu Wuzhong Pharmaceutical Company Information Table 83. Jiangsu Wuzhong Pharmaceutical Business Overview Table 84. Jiangsu Wuzhong Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Jiangsu Wuzhong Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio Table 86. Jiangsu Wuzhong Pharmaceutical Recent Development Table 87. Jiangsu Lianshui Pharmaceutical Company Information Table 88. Jiangsu Lianshui Pharmaceutical Business Overview Table 89. Jiangsu Lianshui Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Jiangsu Lianshui Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio Table 91. Jiangsu Lianshui Pharmaceutical Recent Development Table 92. JSC Pharmstandard Company Information Table 93. JSC Pharmstandard Business Overview Table 94. JSC Pharmstandard Arbidol Hydrochloride (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. JSC Pharmstandard Arbidol Hydrochloride (COVID-19) Product Portfolio Table 96. JSC Pharmstandard Recent Development Table 97. North America Arbidol Hydrochloride (COVID-19) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 98. North America Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2026) & (K Units) Table 99. North America Arbidol Hydrochloride (COVID-19) Sales Market Share by Country (2021-2026) Table 100. North America Arbidol Hydrochloride (COVID-19) Sales Forecast by Country (2027-2032) & (K Units) Table 101. North America Arbidol Hydrochloride (COVID-19) Sales Market Share Forecast by Country (2027-2032) Table 102. North America Arbidol Hydrochloride (COVID-19) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. North America Arbidol Hydrochloride (COVID-19) Market Size by Country (2021-2026) & (US$ Million) Table 104. North America Arbidol Hydrochloride (COVID-19) Market Share by Country (2021-2026) Table 105. North America Arbidol Hydrochloride (COVID-19) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. North America Arbidol Hydrochloride (COVID-19) Market Share Forecast by Country (2027-2032) Table 107. Europe Arbidol Hydrochloride (COVID-19) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. Europe Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2026) & (K Units) Table 109. Europe Arbidol Hydrochloride (COVID-19) Sales Market Share by Country (2021-2026) Table 110. Europe Arbidol Hydrochloride (COVID-19) Sales Forecast by Country (2027-2032) & (K Units) Table 111. Europe Arbidol Hydrochloride (COVID-19) Sales Market Share Forecast by Country (2027-2032) Table 112. Europe Arbidol Hydrochloride (COVID-19) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Europe Arbidol Hydrochloride (COVID-19) Market Size by Country (2021-2026) & (US$ Million) Table 114. Europe Arbidol Hydrochloride (COVID-19) Market Share by Country (2021-2026) Table 115. Europe Arbidol Hydrochloride (COVID-19) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Europe Arbidol Hydrochloride (COVID-19) Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Arbidol Hydrochloride (COVID-19) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2026) & (K Units) Table 119. Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales Market Share by Country (2021-2026) Table 120. Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales Forecast by Country (2027-2032) & (K Units) Table 121. Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Arbidol Hydrochloride (COVID-19) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Arbidol Hydrochloride (COVID-19) Market Size by Country (2021-2026) & (US$ Million) Table 124. Asia-Pacific Arbidol Hydrochloride (COVID-19) Market Share by Country (2021-2026) Table 125. Asia-Pacific Arbidol Hydrochloride (COVID-19) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Asia-Pacific Arbidol Hydrochloride (COVID-19) Market Share Forecast by Country (2027-2032) Table 127. Latin America Arbidol Hydrochloride (COVID-19) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Latin America Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2026) & (K Units) Table 129. Latin America Arbidol Hydrochloride (COVID-19) Sales Market Share by Country (2021-2026) Table 130. Latin America Arbidol Hydrochloride (COVID-19) Sales Forecast by Country (2027-2032) & (K Units) Table 131. Latin America Arbidol Hydrochloride (COVID-19) Sales Market Share Forecast by Country (2027-2032) Table 132. Latin America Arbidol Hydrochloride (COVID-19) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Latin America Arbidol Hydrochloride (COVID-19) Market Size by Country (2021-2026) & (US$ Million) Table 134. Latin America Arbidol Hydrochloride (COVID-19) Market Share by Country (2021-2026) Table 135. Latin America Arbidol Hydrochloride (COVID-19) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Latin America Arbidol Hydrochloride (COVID-19) Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Arbidol Hydrochloride (COVID-19) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales Market Share by Country (2021-2026) Table 140. Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales Forecast by Country (2027-2032) & (K Units) Table 141. Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Arbidol Hydrochloride (COVID-19) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Arbidol Hydrochloride (COVID-19) Market Size by Country (2021-2026) & (US$ Million) Table 144. Middle East and Africa Arbidol Hydrochloride (COVID-19) Market Share by Country (2021-2026) Table 145. Middle East and Africa Arbidol Hydrochloride (COVID-19) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Middle East and Africa Arbidol Hydrochloride (COVID-19) Market Share Forecast by Country (2027-2032) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Arbidol Hydrochloride (COVID-19) Distributors List Table 150. Arbidol Hydrochloride (COVID-19) Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Arbidol Hydrochloride (COVID-19) Image Figure 2. Global Arbidol Hydrochloride (COVID-19) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Arbidol Hydrochloride (COVID-19) Market Size (2021-2032) & (US$ Million) Figure 4. Global Arbidol Hydrochloride (COVID-19) Sales (2021-2032) & (K Units) Figure 5. Arbidol Hydrochloride Capsules Image Figure 6. Global Arbidol Hydrochloride Capsules Sales YoY Growth (2021-2032) & (K Units) Figure 7. Arbidol Hydrochloride Granules Image Figure 8. Global Arbidol Hydrochloride Granules Sales YoY Growth (2021-2032) & (K Units) Figure 9. Arbidol Hydrochloride Tablets Image Figure 10. Global Arbidol Hydrochloride Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Arbidol Hydrochloride (COVID-19) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Arbidol Hydrochloride (COVID-19) Market Share by Type 2025 VS 2032 Figure 13. North America Arbidol Hydrochloride (COVID-19) Sales Market Share in Volume by Type in 2025 Figure 14. North America Arbidol Hydrochloride (COVID-19) Sales Market Share in Value by Type in 2025 Figure 15. Europe Arbidol Hydrochloride (COVID-19) Sales Market Share in Volume by Type in 2025 Figure 16. Europe Arbidol Hydrochloride (COVID-19) Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales Market Share in Value by Type in 2025 Figure 19. Latin America Arbidol Hydrochloride (COVID-19) Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Arbidol Hydrochloride (COVID-19) Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Arbidol Hydrochloride (COVID-19) Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Anti Influenza Virus Image Figure 26. Global Anti Influenza Virus Sales YoY Growth (2021-2032) & (K Units) Figure 27. COVID-19 Image Figure 28. Global COVID-19 Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Arbidol Hydrochloride (COVID-19) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Arbidol Hydrochloride (COVID-19) Market Share by Application 2025 VS 2032 Figure 31. North America Arbidol Hydrochloride (COVID-19) Sales Market Share in Volume by Application in 2025 Figure 32. North America Arbidol Hydrochloride (COVID-19) Sales Market Share in Value by Application in 2025 Figure 33. Europe Arbidol Hydrochloride (COVID-19) Sales Market Share in Volume by Application in 2025 Figure 34. Europe Arbidol Hydrochloride (COVID-19) Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales Market Share in Value by Application in 2025 Figure 37. Latin America Arbidol Hydrochloride (COVID-19) Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Arbidol Hydrochloride (COVID-19) Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales Market Share in Value by Application in 2025 Figure 41. North America Arbidol Hydrochloride (COVID-19) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Arbidol Hydrochloride (COVID-19) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Arbidol Hydrochloride (COVID-19) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Arbidol Hydrochloride (COVID-19) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Arbidol Hydrochloride (COVID-19) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Arbidol Hydrochloride (COVID-19) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Arbidol Hydrochloride (COVID-19) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Arbidol Hydrochloride (COVID-19) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Arbidol Hydrochloride (COVID-19) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Arbidol Hydrochloride (COVID-19) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Arbidol Hydrochloride (COVID-19) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Arbidol Hydrochloride (COVID-19) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Arbidol Hydrochloride (COVID-19) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Arbidol Hydrochloride (COVID-19) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Arbidol Hydrochloride (COVID-19) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Arbidol Hydrochloride (COVID-19) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Arbidol Hydrochloride (COVID-19) Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Arbidol Hydrochloride (COVID-19) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Arbidol Hydrochloride Capsules
  • Arbidol Hydrochloride Granules
  • Arbidol Hydrochloride Tablets
Applications
  • Anti Influenza Virus
  • COVID-19
Companies covered
  • Simcere Pharmaceutical
  • CSPC Ouyi Pharmaceutical
  • Jiangsu Wuzhong Pharmaceutical
  • Jiangsu Lianshui Pharmaceutical
  • JSC Pharmstandard

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Arbidol Hydrochloride (COVID-19) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Arbidol Hydrochloride (COVID-19) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Arbidol Hydrochloride (COVID-19) Market by Type
  6. 1.3.1 Arbidol Hydrochloride Capsules
  7. 1.3.2 Arbidol Hydrochloride Granules
  8. 1.3.3 Arbidol Hydrochloride Tablets
  9. 1.4 Global Arbidol Hydrochloride (COVID-19) Market Size by Type
  10. 1.4.1 Global Arbidol Hydrochloride (COVID-19) Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Arbidol Hydrochloride (COVID-19) Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Arbidol Hydrochloride (COVID-19) Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Arbidol Hydrochloride (COVID-19) Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Arbidol Hydrochloride (COVID-19) Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Arbidol Hydrochloride (COVID-19) Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Arbidol Hydrochloride (COVID-19) Industry Trends
  2. 2.2 Arbidol Hydrochloride (COVID-19) Industry Drivers
  3. 2.3 Arbidol Hydrochloride (COVID-19) Industry Opportunities and Challenges
  4. 2.4 Arbidol Hydrochloride (COVID-19) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Arbidol Hydrochloride (COVID-19) Revenue (2021-2026)
  2. 3.2 Global Top Players by Arbidol Hydrochloride (COVID-19) Sales (2021-2026)
  3. 3.3 Global Top Players by Arbidol Hydrochloride (COVID-19) Price (2021-2026)
  4. 3.4 Global Arbidol Hydrochloride (COVID-19) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Arbidol Hydrochloride (COVID-19) Major Company Production Sites & Headquarters
  6. 3.6 Global Arbidol Hydrochloride (COVID-19) Company, Product Type & Application
  7. 3.7 Global Arbidol Hydrochloride (COVID-19) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Arbidol Hydrochloride (COVID-19) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Arbidol Hydrochloride (COVID-19) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Arbidol Hydrochloride (COVID-19) Tier 1, Tier 2, and Tier 3
4 Arbidol Hydrochloride (COVID-19) Regional Status and Outlook
  1. 4.1 Global Arbidol Hydrochloride (COVID-19) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Arbidol Hydrochloride (COVID-19) Historic Market Size by Region
  3. 4.2.1 Global Arbidol Hydrochloride (COVID-19) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Arbidol Hydrochloride (COVID-19) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Arbidol Hydrochloride (COVID-19) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Arbidol Hydrochloride (COVID-19) Forecasted Market Size by Region
  7. 4.3.1 Global Arbidol Hydrochloride (COVID-19) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Arbidol Hydrochloride (COVID-19) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Arbidol Hydrochloride (COVID-19) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Arbidol Hydrochloride (COVID-19) by Application
  1. 5.1 Arbidol Hydrochloride (COVID-19) Market by Application
  2. 5.1.1 Anti Influenza Virus
  3. 5.1.2 COVID-19
  4. 5.2 Global Arbidol Hydrochloride (COVID-19) Market Size by Application
  5. 5.2.1 Global Arbidol Hydrochloride (COVID-19) Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Arbidol Hydrochloride (COVID-19) Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Arbidol Hydrochloride (COVID-19) Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Arbidol Hydrochloride (COVID-19) Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Arbidol Hydrochloride (COVID-19) Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Arbidol Hydrochloride (COVID-19) Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Simcere Pharmaceutical
  2. 6.1.1 Simcere Pharmaceutical Company Information
  3. 6.1.2 Simcere Pharmaceutical Business Overview
  4. 6.1.3 Simcere Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Simcere Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio
  6. 6.1.5 Simcere Pharmaceutical Recent Developments
  7. 6.2 CSPC Ouyi Pharmaceutical
  8. 6.2.1 CSPC Ouyi Pharmaceutical Company Information
  9. 6.2.2 CSPC Ouyi Pharmaceutical Business Overview
  10. 6.2.3 CSPC Ouyi Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSPC Ouyi Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio
  12. 6.2.5 CSPC Ouyi Pharmaceutical Recent Developments
  13. 6.3 Jiangsu Wuzhong Pharmaceutical
  14. 6.3.1 Jiangsu Wuzhong Pharmaceutical Company Information
  15. 6.3.2 Jiangsu Wuzhong Pharmaceutical Business Overview
  16. 6.3.3 Jiangsu Wuzhong Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangsu Wuzhong Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio
  18. 6.3.5 Jiangsu Wuzhong Pharmaceutical Recent Developments
  19. 6.4 Jiangsu Lianshui Pharmaceutical
  20. 6.4.1 Jiangsu Lianshui Pharmaceutical Company Information
  21. 6.4.2 Jiangsu Lianshui Pharmaceutical Business Overview
  22. 6.4.3 Jiangsu Lianshui Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Jiangsu Lianshui Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio
  24. 6.4.5 Jiangsu Lianshui Pharmaceutical Recent Developments
  25. 6.5 JSC Pharmstandard
  26. 6.5.1 JSC Pharmstandard Company Information
  27. 6.5.2 JSC Pharmstandard Business Overview
  28. 6.5.3 JSC Pharmstandard Arbidol Hydrochloride (COVID-19) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 JSC Pharmstandard Arbidol Hydrochloride (COVID-19) Product Portfolio
  30. 6.5.5 JSC Pharmstandard Recent Developments
7 North America by Country
  1. 7.1 North America Arbidol Hydrochloride (COVID-19) Sales by Country
  2. 7.1.1 North America Arbidol Hydrochloride (COVID-19) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2026)
  4. 7.1.3 North America Arbidol Hydrochloride (COVID-19) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Arbidol Hydrochloride (COVID-19) Market Size by Country
  6. 7.2.1 North America Arbidol Hydrochloride (COVID-19) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Arbidol Hydrochloride (COVID-19) Market Size by Country (2021-2026)
  8. 7.2.3 North America Arbidol Hydrochloride (COVID-19) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Arbidol Hydrochloride (COVID-19) Sales by Country
  2. 8.1.1 Europe Arbidol Hydrochloride (COVID-19) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2026)
  4. 8.1.3 Europe Arbidol Hydrochloride (COVID-19) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Arbidol Hydrochloride (COVID-19) Market Size by Country
  6. 8.2.1 Europe Arbidol Hydrochloride (COVID-19) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Arbidol Hydrochloride (COVID-19) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Arbidol Hydrochloride (COVID-19) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales by Country
  2. 9.1.1 Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Arbidol Hydrochloride (COVID-19) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Arbidol Hydrochloride (COVID-19) Market Size by Country
  6. 9.2.1 Asia-Pacific Arbidol Hydrochloride (COVID-19) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Arbidol Hydrochloride (COVID-19) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Arbidol Hydrochloride (COVID-19) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Arbidol Hydrochloride (COVID-19) Sales by Country
  2. 10.1.1 South America Arbidol Hydrochloride (COVID-19) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2026)
  4. 10.1.3 South America Arbidol Hydrochloride (COVID-19) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Arbidol Hydrochloride (COVID-19) Market Size by Country
  6. 10.2.1 South America Arbidol Hydrochloride (COVID-19) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Arbidol Hydrochloride (COVID-19) Market Size by Country (2021-2026)
  8. 10.2.3 South America Arbidol Hydrochloride (COVID-19) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales by Country
  2. 11.1.1 Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Arbidol Hydrochloride (COVID-19) Market Size by Country
  6. 11.2.1 Middle East and Africa Arbidol Hydrochloride (COVID-19) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Arbidol Hydrochloride (COVID-19) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Arbidol Hydrochloride (COVID-19) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Arbidol Hydrochloride (COVID-19) Value Chain Analysis
  2. 12.1.1 Arbidol Hydrochloride (COVID-19) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Arbidol Hydrochloride (COVID-19) Production Mode & Process
  7. 12.2 Arbidol Hydrochloride (COVID-19) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Arbidol Hydrochloride (COVID-19) Distributors
  10. 12.2.3 Arbidol Hydrochloride (COVID-19) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst